Pandori William J, Matsuno Stephanie Y, Shin Ji-Hun, Kim Samuel C, Kao Tiffany H, Mallya Sharmila, Batarseh Sarah N, Lodoen Melissa B
Department of Molecular Biology & Biochemistry and the Institute for Immunology, University of California, Irvine, CA.
J Immunol. 2024 Apr 1;212(7):1161-1171. doi: 10.4049/jimmunol.2200513.
Monocytes are actively recruited to sites of infection and produce the potent proinflammatory cytokine IL-1β. We previously showed that IL-1β release during Toxoplasma gondii infection of primary human monocytes requires the NLRP3 inflammasome and caspase-1 but is independent of gasdermin D and pyroptosis. To investigate mechanisms of IL-1β release, we generated caspase-1, -4, -5, or -8 knockout (KO) THP-1 monocytic cells. Genetic ablation of caspase-1 or -8, but not caspase-4 or -5, decreased IL-1β release during T. gondii infection without affecting cell death. In contrast, TNF-α and IL-6 secretion were unperturbed in caspase-8 KO cells during T. gondii infection. Dual pharmacological inhibition of caspase-8 and RIPK1 in primary monocytes also decreased IL-1β release without affecting cell viability or parasite infection. Caspase-8 was also required for the release of active caspase-1 from T. gondii-infected cells and for IL-1β release during infection with the related apicomplexan parasite Neospora caninum. Surprisingly, caspase-8 deficiency did not impair synthesis or cleavage of pro-IL-1β, but resulted in the retention of mature IL-1β within cells. Generation of gasdermin E KO and ATG7 KO THP-1 cells revealed that the release of IL-1β was not dependent on gasdermin E or ATG7. Collectively, our data indicate that during T. gondii Infection of human monocytes, caspase-8 functions in a novel gasdermin-independent mechanism controlling IL-1β release from viable cells. This study expands on the molecular pathways that promote IL-1β in human immune cells and provides evidence of a role for caspase-8 in the mechanism of IL-1β release during infection.
单核细胞被积极招募到感染部位,并产生强效促炎细胞因子白细胞介素-1β(IL-1β)。我们之前表明,在原发性人类单核细胞感染刚地弓形虫期间,IL-1β的释放需要NLRP3炎性小体和半胱天冬酶-1,但不依赖于gasdermin D和细胞焦亡。为了研究IL-1β释放的机制,我们构建了半胱天冬酶-1、-4、-5或-8基因敲除(KO)的THP-1单核细胞。在刚地弓形虫感染期间,半胱天冬酶-1或-8的基因缺失而非半胱天冬酶-4或-5的缺失,会降低IL-1β的释放,且不影响细胞死亡。相比之下,在刚地弓形虫感染期间,半胱天冬酶-8基因敲除细胞中肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)的分泌未受干扰。在原发性单核细胞中对半胱天冬酶-8和受体相互作用蛋白激酶1(RIPK1)进行双重药理学抑制,也会降低IL-1β的释放,且不影响细胞活力或寄生虫感染。在刚地弓形虫感染的细胞中,释放活性半胱天冬酶-1以及在感染相关顶复门寄生虫犬新孢子虫期间释放IL-1β也都需要半胱天冬酶-8。令人惊讶的是,半胱天冬酶-8缺陷并不损害前体IL-1β的合成或切割,但会导致成熟IL-1β在细胞内潴留。构建gasdermin E基因敲除和自噬相关蛋白7(ATG7)基因敲除的THP-1细胞表明,IL-1β的释放不依赖于gasdermin E或ATG7。总的来说,我们的数据表明,在人类单核细胞感染刚地弓形虫期间,半胱天冬酶-8通过一种新的不依赖于gasdermin的机制发挥作用,控制IL-1β从存活细胞中的释放。这项研究扩展了促进人类免疫细胞中IL-1β释放的分子途径,并为半胱天冬酶-8在感染期间IL-1β释放机制中的作用提供了证据。